Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there's a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.
We personally invite you to join us at Pegasus Park in Dallas on Wednesday, September 28 to partake in thought provoking panel discussions. Plus, this event offers an 8:1 ratio of attendees to investors for those seeking funding and a desire to network.
Don't miss this valuable opportunity to save $100 with our Early Bird Rate (ends 8/26).
Neenah, Wisconsin-based health system ThedaCare announced it is investing $3 million into Qventus, a SaaS company that uses artificial intelligence to automate care operations. The health system will collaborate with Qventus to develop new products, as well as support the company in expanding its technology to additional hospitals across the country.
Gilead Sciences said it has statistically significant and clinically meaningful data from a pivotal test of its cancer drug, Trodelvy, in the most common type of breast cancer. While detailed data remain undisclosed, the company said it has filed a submission with the FDA seeking to expand the drug's approval to include this larger group of breast cancer patients.
Nanopath, a women's health diagnostics startup, recently closed a $10 million in Series A funding round. The company will use the money to develop and commercialize its platform, which aims to diagnose women's pelvic and gynecologic infections within minutes.
By Marissa Plescia Monday, August 15, 2022 2:49 PM
Healthpilot uses an AI-driven platform to help consumers determine what Medicare plan is best for them. On the startup's website, users can input their location, physicians, prescriptions, pharmacies and what benefits they want, and the algorithm will recommend the plan it believes is most cost-effective.
By Vijay Yanamadala, Michael Adelberg and Vincent Giglierano Monday, August 15, 2022 2:30 PM
Digital physical therapy services, long offered in Europe but are new in the U.S., offer American patients a new way to access PT and have given U.S. health plans a way to reduce costs compared to conventional PT.
The wet form of age-related macular degeneration (AMD) is currently treated with eye drugs that are blockbuster sellers. Opthea Limited is developing a wet AMD drug that goes after different targets and the biotech struck a pair of financing deals that provide it with the cash for pivotal tests that could show how well its approach works.
AMD in particular impacts as many as 11 million Americans. About 15% of those affected have neovascular or wet AMD. It's a devastating disease that can lead to irreversible vision loss.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments